| 0 |
ALLERGENIC DESENSITISATION PROCEDURE |
1 |
0.2000 |
| 1 |
BIOPSY LIP |
1 |
0.1000 |
| 2 |
ACHROMOTRICHIA ACQUIRED |
3 |
0.0612 |
| 3 |
ANGIOTENSIN CONVERTING ENZYME DECREASED |
1 |
0.0588 |
| 4 |
EYEBALL AVULSION |
2 |
0.0513 |
| 5 |
ABORTION INDUCED COMPLETE |
1 |
0.0345 |
| 6 |
ACNE CYSTIC |
84 |
0.0279 |
| 7 |
ACNE FULMINANS |
5 |
0.0255 |
| 8 |
CHEMICAL BURN OF SKIN |
60 |
0.0236 |
| 9 |
SEBORRHOEA |
86 |
0.0234 |
| 10 |
ALBUMIN URINE |
1 |
0.0227 |
| 11 |
DILATED PORES |
2 |
0.0220 |
| 12 |
ACNE PUSTULAR |
17 |
0.0207 |
| 13 |
ACNE |
1480 |
0.0195 |
| 14 |
SKIN IRRITATION |
869 |
0.0190 |
| 15 |
SENSITIVE SKIN |
127 |
0.0172 |
| 16 |
ARCUS LIPOIDES |
1 |
0.0159 |
| 17 |
SKIN FRAGILITY |
36 |
0.0148 |
| 18 |
SKIN BURNING SENSATION |
975 |
0.0136 |
| 19 |
SKIN HYPOPIGMENTATION |
24 |
0.0136 |
| 20 |
AUTOPHONY |
1 |
0.0133 |
| 21 |
SKIN HYPERPIGMENTATION |
114 |
0.0133 |
| 22 |
ACTINIC ELASTOSIS |
1 |
0.0132 |
| 23 |
AMMONIA DECREASED |
1 |
0.0128 |
| 24 |
PAIN OF SKIN |
320 |
0.0119 |
| 25 |
APPLICATION SITE ECZEMA |
1 |
0.0115 |
| 26 |
DRY SKIN |
1509 |
0.0113 |
| 27 |
BASE EXCESS INCREASED |
1 |
0.0112 |
| 28 |
CHEMICAL BURN |
12 |
0.0104 |
| 29 |
SKIN DISCOMFORT |
28 |
0.0104 |
| 30 |
ATYPICAL MYCOBACTERIUM TEST POSITIVE |
1 |
0.0103 |
| 31 |
MEDICAL DIET |
2 |
0.0102 |
| 32 |
SKIN SWELLING |
88 |
0.0101 |
| 33 |
BAND NEUTROPHIL PERCENTAGE INCREASED |
1 |
0.0096 |
| 34 |
SKIN TIGHTNESS |
44 |
0.0093 |
| 35 |
AMIMIA |
1 |
0.0091 |
| 36 |
CHEMICAL INJURY |
7 |
0.0086 |
| 37 |
PILONIDAL DISEASE |
2 |
0.0083 |
| 38 |
APPLICATION SITE PUSTULES |
3 |
0.0082 |
| 39 |
ABDOMINAL WALL MASS |
1 |
0.0082 |
| 40 |
SKIN DISCHARGE |
3 |
0.0079 |
| 41 |
EYELID EXFOLIATION |
6 |
0.0076 |
| 42 |
BASAL GANGLIA STROKE |
1 |
0.0069 |
| 43 |
POLYARTERITIS NODOSA |
4 |
0.0068 |
| 44 |
SKIN EXFOLIATION |
562 |
0.0067 |
| 45 |
AORTIC VALVE THICKENING |
1 |
0.0062 |
| 46 |
APPLICATION SITE OEDEMA |
2 |
0.0062 |
| 47 |
ERYTHEMA |
1162 |
0.0056 |
| 48 |
ENDOMETRIAL ABLATION |
2 |
0.0056 |
| 49 |
PNEUMOMEDIASTINUM |
10 |
0.0055 |
| 50 |
MILIA |
2 |
0.0055 |
| 51 |
RASH PAPULAR |
120 |
0.0053 |
| 52 |
APPLICATION SITE INJURY |
1 |
0.0053 |
| 53 |
ILEITIS |
2 |
0.0052 |
| 54 |
ANAL ULCER |
4 |
0.0049 |
| 55 |
APPLICATION SITE SWELLING |
24 |
0.0048 |
| 56 |
ADULT FAILURE TO THRIVE |
1 |
0.0047 |
| 57 |
SCAR |
80 |
0.0047 |
| 58 |
NECROTISING MYOSITIS |
4 |
0.0046 |
| 59 |
SKIN INJURY |
15 |
0.0045 |
| 60 |
CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS |
2 |
0.0045 |
| 61 |
PERINEAL ABSCESS |
2 |
0.0044 |
| 62 |
POST INFLAMMATORY PIGMENTATION CHANGE |
2 |
0.0044 |
| 63 |
ALBUMIN GLOBULIN RATIO DECREASED |
1 |
0.0043 |
| 64 |
MECHANICAL URTICARIA |
2 |
0.0043 |
| 65 |
SWELLING FACE |
269 |
0.0041 |
| 66 |
COLON ADENOMA |
4 |
0.0041 |
| 67 |
EYE SWELLING |
151 |
0.0041 |
| 68 |
BLADDER DISCOMFORT |
5 |
0.0040 |
| 69 |
APPLICATION SITE WARMTH |
5 |
0.0039 |
| 70 |
APPLICATION SITE PAPULES |
4 |
0.0038 |
| 71 |
LIP ERYTHEMA |
3 |
0.0038 |
| 72 |
PERIORBITAL CELLULITIS |
2 |
0.0037 |
| 73 |
LEFT ATRIAL ENLARGEMENT |
2 |
0.0037 |
| 74 |
ABDOMINAL WOUND DEHISCENCE |
1 |
0.0037 |
| 75 |
DERMATITIS |
75 |
0.0036 |
| 76 |
ENTEROBACTER INFECTION |
6 |
0.0036 |
| 77 |
AVULSION FRACTURE |
1 |
0.0035 |
| 78 |
LYMPHOCYTE MORPHOLOGY ABNORMAL |
2 |
0.0035 |
| 79 |
EOSINOPHILIC PNEUMONIA ACUTE |
3 |
0.0035 |
| 80 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
624 |
0.0035 |
| 81 |
BACTERIAL TEST |
1 |
0.0034 |
| 82 |
PROCTITIS ULCERATIVE |
2 |
0.0033 |
| 83 |
ALLERGY TO METALS |
2 |
0.0033 |
| 84 |
APPLICATION SITE DRYNESS |
11 |
0.0032 |
| 85 |
EYELID IRRITATION |
8 |
0.0032 |
| 86 |
PERIORAL DERMATITIS |
2 |
0.0031 |
| 87 |
SKIN TEXTURE ABNORMAL |
3 |
0.0031 |
| 88 |
ASPERGILLOMA |
1 |
0.0031 |
| 89 |
BENIGN NEOPLASM OF SKIN |
1 |
0.0030 |
| 90 |
SKIN WARM |
17 |
0.0029 |
| 91 |
BASAL GANGLIA INFARCTION |
1 |
0.0029 |
| 92 |
ATHEROSCLEROSIS |
1 |
0.0029 |
| 93 |
DERMATITIS CONTACT |
33 |
0.0029 |
| 94 |
APPLICATION SITE INFLAMMATION |
4 |
0.0029 |
| 95 |
ASTHMA EXERCISE INDUCED |
1 |
0.0029 |
| 96 |
SWELLING OF EYELID |
18 |
0.0029 |
| 97 |
BURNS THIRD DEGREE |
3 |
0.0028 |
| 98 |
GASTROINTESTINAL OEDEMA |
5 |
0.0028 |
| 99 |
JUGULAR VEIN THROMBOSIS |
5 |
0.0028 |
| 100 |
UNDERDOSE |
199 |
0.0027 |
| 101 |
SMALL INTESTINAL PERFORATION |
5 |
0.0027 |
| 102 |
SKIN FISSURES |
52 |
0.0027 |
| 103 |
RASH MACULAR |
93 |
0.0027 |
| 104 |
APPLICATION SITE DISCHARGE |
3 |
0.0026 |
| 105 |
ADENOIDECTOMY |
1 |
0.0026 |
| 106 |
PUSTULE |
6 |
0.0025 |
| 107 |
EYELID SKIN DRYNESS |
3 |
0.0025 |
| 108 |
XEROSIS |
3 |
0.0024 |
| 109 |
SEBORRHOEIC DERMATITIS |
4 |
0.0024 |
| 110 |
HIDRADENITIS |
22 |
0.0024 |
| 111 |
PERIORBITAL PAIN |
2 |
0.0024 |
| 112 |
ROSACEA |
11 |
0.0024 |
| 113 |
CYSTOCELE |
2 |
0.0023 |
| 114 |
PERIORBITAL SWELLING |
13 |
0.0023 |
| 115 |
BURNS SECOND DEGREE |
4 |
0.0023 |
| 116 |
OVERDOSE |
491 |
0.0023 |
| 117 |
LARGE INTESTINAL OBSTRUCTION |
5 |
0.0022 |
| 118 |
NEUROPSYCHIATRIC SYMPTOMS |
2 |
0.0022 |
| 119 |
ALLERGY TEST POSITIVE |
1 |
0.0022 |
| 120 |
SCAB |
25 |
0.0022 |
| 121 |
CEREBRAL ISCHAEMIA |
11 |
0.0021 |
| 122 |
SMEAR CERVIX ABNORMAL |
3 |
0.0021 |
| 123 |
SKIN HAEMORRHAGE |
31 |
0.0021 |
| 124 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 125 |
PULMONARY VALVE INCOMPETENCE |
3 |
0.0021 |
| 126 |
DERMAL CYST |
5 |
0.0020 |
| 127 |
ERYTHEMA OF EYELID |
11 |
0.0020 |
| 128 |
BLEPHARAL PIGMENTATION |
1 |
0.0020 |
| 129 |
EYELID PAIN |
4 |
0.0020 |
| 130 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 131 |
SKIN INFECTION |
22 |
0.0020 |
| 132 |
PHARYNGEAL OEDEMA |
30 |
0.0019 |
| 133 |
APPLICATION SITE EXFOLIATION |
8 |
0.0019 |
| 134 |
MULTIPLE-DRUG RESISTANCE |
6 |
0.0019 |
| 135 |
SKIN DISCOLOURATION |
88 |
0.0019 |
| 136 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
2 |
0.0019 |
| 137 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
2 |
0.0019 |
| 138 |
SKIN EROSION |
6 |
0.0019 |
| 139 |
SKIN WRINKLING |
5 |
0.0018 |
| 140 |
CATHETER SITE DISCHARGE |
2 |
0.0018 |
| 141 |
SKIN HYPERTROPHY |
5 |
0.0018 |
| 142 |
THROAT TIGHTNESS |
48 |
0.0018 |
| 143 |
HYPERSENSITIVITY |
328 |
0.0018 |
| 144 |
APPLICATION SITE DISCOLOURATION |
7 |
0.0017 |
| 145 |
AORTIC CALCIFICATION |
1 |
0.0017 |
| 146 |
ADENOMYOSIS |
1 |
0.0017 |
| 147 |
NASAL OEDEMA |
3 |
0.0017 |
| 148 |
RASH ERYTHEMATOUS |
79 |
0.0017 |
| 149 |
APPLICATION SITE HYPERSENSITIVITY |
2 |
0.0016 |
| 150 |
DERMATITIS ACNEIFORM |
10 |
0.0016 |
| 151 |
FURUNCLE |
13 |
0.0016 |
| 152 |
STAPHYLOCOCCAL SKIN INFECTION |
2 |
0.0016 |
| 153 |
POST-ACUTE COVID-19 SYNDROME |
2 |
0.0016 |
| 154 |
CHAPPED LIPS |
7 |
0.0016 |
| 155 |
ALLERGY TO CHEMICALS |
2 |
0.0016 |
| 156 |
PRODUCT USED FOR UNKNOWN INDICATION |
2 |
0.0016 |
| 157 |
BACILLUS INFECTION |
1 |
0.0016 |
| 158 |
SKIN REACTION |
22 |
0.0016 |
| 159 |
PAPULE |
11 |
0.0016 |
| 160 |
WISDOM TEETH REMOVAL |
2 |
0.0015 |
| 161 |
HIRSUTISM |
2 |
0.0015 |
| 162 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
1 |
0.0015 |
| 163 |
SKIN MASS |
10 |
0.0015 |
| 164 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 165 |
LYMPHOCYTE PERCENTAGE DECREASED |
2 |
0.0015 |
| 166 |
SKIN ABRASION |
7 |
0.0015 |
| 167 |
CORNEAL ABRASION |
2 |
0.0015 |
| 168 |
APPLICATION SITE ERYTHEMA |
38 |
0.0014 |
| 169 |
DRUG INEFFECTIVE |
1899 |
0.0014 |
| 170 |
APPLICATION SITE BURN |
7 |
0.0014 |
| 171 |
APPLICATION SITE SCAB |
3 |
0.0014 |
| 172 |
SEBORRHOEIC KERATOSIS |
2 |
0.0014 |
| 173 |
EYELID OEDEMA |
16 |
0.0014 |
| 174 |
ATROPHIC VULVOVAGINITIS |
1 |
0.0014 |
| 175 |
INTENTIONAL UNDERDOSE |
10 |
0.0014 |
| 176 |
DARK CIRCLES UNDER EYES |
2 |
0.0014 |
| 177 |
PRECANCEROUS SKIN LESION |
2 |
0.0014 |
| 178 |
BLISTER RUPTURE |
1 |
0.0013 |
| 179 |
ARTERIAL INJURY |
1 |
0.0013 |
| 180 |
EMBOLISM |
11 |
0.0013 |
| 181 |
APPLICATION SITE PAIN |
29 |
0.0013 |
| 182 |
PRURITUS |
504 |
0.0013 |
| 183 |
PANCREATITIS NECROTISING |
3 |
0.0013 |
| 184 |
LIP SWELLING |
43 |
0.0013 |
| 185 |
POLYCYSTIC OVARIES |
2 |
0.0013 |
| 186 |
EYELIDS PRURITUS |
4 |
0.0013 |
| 187 |
PRODUCT ADMINISTRATION INTERRUPTED |
10 |
0.0013 |
| 188 |
DERMATITIS ALLERGIC |
16 |
0.0013 |
| 189 |
PULMONARY INFARCTION |
3 |
0.0013 |
| 190 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
12 |
0.0013 |
| 191 |
OPTIC NERVE DISORDER |
2 |
0.0012 |
| 192 |
COSTOCHONDRITIS |
2 |
0.0012 |
| 193 |
HYPERPARATHYROIDISM SECONDARY |
3 |
0.0012 |
| 194 |
TONSILLAR HYPERTROPHY |
2 |
0.0012 |
| 195 |
URTICARIA |
199 |
0.0012 |
| 196 |
TYMPANIC MEMBRANE PERFORATION |
2 |
0.0012 |
| 197 |
BLOOD CHLORIDE DECREASED |
3 |
0.0012 |
| 198 |
ACUTE SINUSITIS |
2 |
0.0012 |
| 199 |
TONGUE COATED |
2 |
0.0012 |
| 200 |
CATHETER SITE PAIN |
3 |
0.0012 |
| 201 |
SCRATCH |
12 |
0.0011 |
| 202 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
3 |
0.0011 |
| 203 |
ANOGENITAL WARTS |
1 |
0.0011 |
| 204 |
SKIN WEEPING |
4 |
0.0011 |
| 205 |
APPLICATION SITE DISCOMFORT |
2 |
0.0011 |
| 206 |
OBSESSIVE THOUGHTS |
2 |
0.0011 |
| 207 |
LIP DRY |
10 |
0.0011 |
| 208 |
RASH |
479 |
0.0011 |
| 209 |
ABULIA |
1 |
0.0011 |
| 210 |
MACULE |
3 |
0.0011 |
| 211 |
NEPHROGENIC ANAEMIA |
5 |
0.0011 |
| 212 |
APPLICATION SITE VESICLES |
7 |
0.0011 |
| 213 |
PROCTITIS |
3 |
0.0011 |
| 214 |
SACROILIITIS |
2 |
0.0011 |
| 215 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 216 |
RESPIRATORY SYMPTOM |
3 |
0.0011 |
| 217 |
SUBCUTANEOUS ABSCESS |
5 |
0.0010 |
| 218 |
MOUTH SWELLING |
6 |
0.0010 |
| 219 |
VULVOVAGINAL PAIN |
5 |
0.0010 |
| 220 |
BILIARY COLIC |
3 |
0.0010 |
| 221 |
PURULENCE |
2 |
0.0010 |
| 222 |
MULTI-ORGAN DISORDER |
2 |
0.0010 |
| 223 |
SKIN PAPILLOMA |
4 |
0.0010 |
| 224 |
DERMATITIS PSORIASIFORM |
2 |
0.0010 |
| 225 |
PERSONALITY CHANGE |
9 |
0.0010 |
| 226 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
2 |
0.0010 |
| 227 |
SKIN INDURATION |
2 |
0.0010 |
| 228 |
BLISTER |
54 |
0.0010 |
| 229 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
43 |
0.0010 |
| 230 |
FOLLICULITIS |
10 |
0.0010 |
| 231 |
PHARYNGEAL ERYTHEMA |
2 |
0.0009 |
| 232 |
SUNBURN |
7 |
0.0009 |
| 233 |
CATHETER SITE ERYTHEMA |
2 |
0.0009 |
| 234 |
INFLAMMATORY BOWEL DISEASE |
9 |
0.0009 |
| 235 |
OEDEMA MOUTH |
3 |
0.0009 |
| 236 |
OESOPHAGITIS |
10 |
0.0009 |
| 237 |
CEREBELLAR SYNDROME |
2 |
0.0009 |
| 238 |
CORNEAL DISORDER |
2 |
0.0009 |
| 239 |
FEAR OF DEATH |
2 |
0.0009 |
| 240 |
CYST |
11 |
0.0009 |
| 241 |
CROHN'S DISEASE |
6 |
0.0009 |
| 242 |
INFUSION SITE INFECTION |
2 |
0.0009 |
| 243 |
LOCAL SWELLING |
15 |
0.0009 |
| 244 |
INGROWING NAIL |
2 |
0.0008 |
| 245 |
ENDOMETRIOSIS |
4 |
0.0008 |
| 246 |
RASH VESICULAR |
4 |
0.0008 |
| 247 |
RASH PUSTULAR |
6 |
0.0008 |
| 248 |
NEURODERMATITIS |
3 |
0.0008 |
| 249 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
57 |
0.0008 |
| 250 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 251 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
3 |
0.0008 |
| 252 |
BENIGN INTRACRANIAL HYPERTENSION |
1 |
0.0008 |
| 253 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 254 |
TONGUE OEDEMA |
3 |
0.0008 |
| 255 |
LACTOSE INTOLERANCE |
2 |
0.0008 |
| 256 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 257 |
LIPOMA |
2 |
0.0008 |
| 258 |
ABDOMINAL OPERATION |
1 |
0.0008 |
| 259 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 260 |
ABNORMAL SLEEP-RELATED EVENT |
1 |
0.0008 |
| 261 |
ACROCHORDON |
1 |
0.0008 |
| 262 |
PROTEIN TOTAL INCREASED |
2 |
0.0008 |
| 263 |
CHOLECYSTITIS CHRONIC |
5 |
0.0007 |
| 264 |
WEIGHT BEARING DIFFICULTY |
2 |
0.0007 |
| 265 |
CHEILITIS |
4 |
0.0007 |
| 266 |
APPLICATION SITE HAEMORRHAGE |
2 |
0.0007 |
| 267 |
ACUTE RESPIRATORY FAILURE |
14 |
0.0007 |
| 268 |
APPLICATION SITE RASH |
10 |
0.0007 |
| 269 |
RED CELL DISTRIBUTION WIDTH INCREASED |
3 |
0.0007 |
| 270 |
DYSTONIA |
14 |
0.0007 |
| 271 |
ANAL HAEMORRHAGE |
2 |
0.0007 |
| 272 |
CEREBRAL THROMBOSIS |
2 |
0.0007 |
| 273 |
BREAST CANCER STAGE IV |
2 |
0.0007 |
| 274 |
THERMAL BURN |
5 |
0.0007 |
| 275 |
PURULENT DISCHARGE |
3 |
0.0007 |
| 276 |
MICTURITION URGENCY |
8 |
0.0007 |
| 277 |
SKIN CANCER |
15 |
0.0007 |
| 278 |
SKIN ATROPHY |
4 |
0.0007 |
| 279 |
PNEUMOTHORAX |
11 |
0.0007 |
| 280 |
ANKLE OPERATION |
1 |
0.0007 |
| 281 |
ADHESION |
1 |
0.0007 |
| 282 |
APPLICATION SITE PRURITUS |
15 |
0.0007 |
| 283 |
EYE IRRITATION |
38 |
0.0007 |
| 284 |
PORTAL HYPERTENSION |
2 |
0.0006 |
| 285 |
PIGMENTATION DISORDER |
4 |
0.0006 |
| 286 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
5 |
0.0006 |
| 287 |
YELLOW SKIN |
3 |
0.0006 |
| 288 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 289 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 290 |
CONDITION AGGRAVATED |
193 |
0.0006 |
| 291 |
ANGIOEDEMA |
28 |
0.0006 |
| 292 |
ECZEMA |
33 |
0.0006 |
| 293 |
APHAGIA |
3 |
0.0006 |
| 294 |
PRODUCT USE IN UNAPPROVED INDICATION |
154 |
0.0006 |
| 295 |
SKIN ULCER |
16 |
0.0006 |
| 296 |
BURNING SENSATION |
43 |
0.0006 |
| 297 |
PHOTOSENSITIVITY REACTION |
10 |
0.0006 |
| 298 |
ADVERSE REACTION |
8 |
0.0006 |
| 299 |
EOSINOPHIL COUNT INCREASED |
5 |
0.0006 |
| 300 |
POST-TRAUMATIC STRESS DISORDER |
4 |
0.0006 |
| 301 |
POTENTIATING DRUG INTERACTION |
2 |
0.0006 |
| 302 |
LACRIMATION INCREASED |
18 |
0.0006 |
| 303 |
ECONOMIC PROBLEM |
9 |
0.0006 |
| 304 |
OCULAR HYPERAEMIA |
28 |
0.0006 |
| 305 |
NOCTURIA |
7 |
0.0006 |
| 306 |
SWOLLEN TONGUE |
18 |
0.0006 |
| 307 |
CAROTID ARTERY STENOSIS |
2 |
0.0006 |
| 308 |
ANHEDONIA |
15 |
0.0006 |
| 309 |
SENSITIVITY TO WEATHER CHANGE |
3 |
0.0006 |
| 310 |
ALOPECIA AREATA |
1 |
0.0006 |
| 311 |
APPLICATION SITE REACTION |
4 |
0.0006 |
| 312 |
EYE PRURITUS |
19 |
0.0006 |
| 313 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
10 |
0.0006 |
| 314 |
ANAL FISTULA |
3 |
0.0006 |
| 315 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
4 |
0.0006 |
| 316 |
LUPUS-LIKE SYNDROME |
5 |
0.0006 |
| 317 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
3 |
0.0005 |
| 318 |
WOUND HAEMORRHAGE |
2 |
0.0005 |
| 319 |
HYPERACUSIS |
2 |
0.0005 |
| 320 |
FLANK PAIN |
5 |
0.0005 |
| 321 |
BLOOD BICARBONATE DECREASED |
1 |
0.0005 |
| 322 |
HYPERTONIA |
3 |
0.0005 |
| 323 |
IRRITABLE BOWEL SYNDROME |
11 |
0.0005 |
| 324 |
EPIGASTRIC DISCOMFORT |
2 |
0.0005 |
| 325 |
PROCEDURAL HAEMORRHAGE |
2 |
0.0005 |
| 326 |
AFFECTIVE DISORDER |
4 |
0.0005 |
| 327 |
SKIN ODOUR ABNORMAL |
2 |
0.0005 |
| 328 |
ANAPHYLACTIC REACTION |
28 |
0.0005 |
| 329 |
TRICUSPID VALVE INCOMPETENCE |
4 |
0.0005 |
| 330 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 331 |
CANDIDIASIS |
2 |
0.0005 |
| 332 |
ORGAN FAILURE |
2 |
0.0005 |
| 333 |
FUNGAL SKIN INFECTION |
2 |
0.0005 |
| 334 |
ENURESIS |
2 |
0.0005 |
| 335 |
GOITRE |
2 |
0.0005 |
| 336 |
TENDERNESS |
5 |
0.0005 |
| 337 |
RASH PRURITIC |
26 |
0.0005 |
| 338 |
SELF-INJURIOUS IDEATION |
2 |
0.0005 |
| 339 |
SLEEP TERROR |
2 |
0.0005 |
| 340 |
FACE OEDEMA |
8 |
0.0005 |
| 341 |
SKIN PLAQUE |
4 |
0.0005 |
| 342 |
SKIN LESION |
13 |
0.0005 |
| 343 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
26 |
0.0005 |
| 344 |
LIP OEDEMA |
2 |
0.0005 |
| 345 |
SLEEP APNOEA SYNDROME |
9 |
0.0005 |
| 346 |
SHOULDER OPERATION |
2 |
0.0005 |
| 347 |
LEFT VENTRICULAR HYPERTROPHY |
2 |
0.0005 |
| 348 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 349 |
SKIN LACERATION |
5 |
0.0005 |
| 350 |
IMMOBILE |
2 |
0.0005 |
| 351 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 352 |
GROIN PAIN |
4 |
0.0005 |
| 353 |
RHINITIS ALLERGIC |
2 |
0.0004 |
| 354 |
FACIAL PAIN |
4 |
0.0004 |
| 355 |
BREAST MASS |
3 |
0.0004 |
| 356 |
REBOUND EFFECT |
5 |
0.0004 |
| 357 |
MITRAL VALVE INCOMPETENCE |
5 |
0.0004 |
| 358 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 359 |
BUNDLE BRANCH BLOCK RIGHT |
2 |
0.0004 |
| 360 |
DYSPAREUNIA |
2 |
0.0004 |
| 361 |
INTERVERTEBRAL DISC DEGENERATION |
4 |
0.0004 |
| 362 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 363 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 364 |
AUTOIMMUNE DISORDER |
4 |
0.0004 |
| 365 |
PRODUCT USE ISSUE |
77 |
0.0004 |
| 366 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
1 |
0.0004 |
| 367 |
NIGHTMARE |
14 |
0.0004 |
| 368 |
PHARYNGITIS |
5 |
0.0004 |
| 369 |
INJECTION SITE DISCOLOURATION |
5 |
0.0004 |
| 370 |
BLOOD TRIGLYCERIDES INCREASED |
7 |
0.0004 |
| 371 |
SWELLING |
37 |
0.0004 |
| 372 |
TOOTH ABSCESS |
4 |
0.0004 |
| 373 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 374 |
DEVICE DISLOCATION |
17 |
0.0004 |
| 375 |
INCREASED UPPER AIRWAY SECRETION |
2 |
0.0004 |
| 376 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 377 |
VARICOSE VEIN |
2 |
0.0004 |
| 378 |
INTENTIONAL DOSE OMISSION |
11 |
0.0004 |
| 379 |
PERIORBITAL OEDEMA |
2 |
0.0004 |
| 380 |
EYE DISCHARGE |
4 |
0.0004 |
| 381 |
ELECTROCARDIOGRAM ABNORMAL |
3 |
0.0004 |
| 382 |
BLOOD ALBUMIN DECREASED |
3 |
0.0004 |
| 383 |
ABSCESS |
6 |
0.0004 |
| 384 |
ANGIONEUROTIC OEDEMA |
1 |
0.0004 |
| 385 |
FEELING HOT |
23 |
0.0004 |
| 386 |
BRUXISM |
2 |
0.0004 |
| 387 |
ABDOMINAL RIGIDITY |
1 |
0.0004 |
| 388 |
ANORGASMIA |
1 |
0.0004 |
| 389 |
BIPOLAR DISORDER |
4 |
0.0004 |
| 390 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
2 |
0.0004 |
| 391 |
IMPAIRED GASTRIC EMPTYING |
5 |
0.0004 |
| 392 |
HYPERAESTHESIA |
3 |
0.0004 |
| 393 |
ASTHENOPIA |
2 |
0.0004 |
| 394 |
SKIN DISORDER |
12 |
0.0004 |
| 395 |
OBSTRUCTIVE AIRWAYS DISORDER |
4 |
0.0004 |
| 396 |
STREPTOCOCCAL INFECTION |
2 |
0.0004 |
| 397 |
HUNGER |
5 |
0.0004 |
| 398 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 399 |
EYE INFECTION |
4 |
0.0004 |
| 400 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 401 |
GRANULOCYTOPENIA |
2 |
0.0004 |
| 402 |
NEUROLOGICAL SYMPTOM |
2 |
0.0003 |
| 403 |
RASH GENERALISED |
9 |
0.0003 |
| 404 |
MUSCLE STRAIN |
3 |
0.0003 |
| 405 |
PANCREATIC CARCINOMA |
10 |
0.0003 |
| 406 |
HYPERVENTILATION |
2 |
0.0003 |
| 407 |
ADENOVIRUS INFECTION |
1 |
0.0003 |
| 408 |
HYPOVOLAEMIA |
2 |
0.0003 |
| 409 |
SPINAL OSTEOARTHRITIS |
3 |
0.0003 |
| 410 |
SPLENOMEGALY |
4 |
0.0003 |
| 411 |
GLUCOSE TOLERANCE IMPAIRED |
2 |
0.0003 |
| 412 |
PARAESTHESIA |
53 |
0.0003 |
| 413 |
ODYNOPHAGIA |
2 |
0.0003 |
| 414 |
PROTHROMBIN TIME PROLONGED |
2 |
0.0003 |
| 415 |
THERAPY NON-RESPONDER |
15 |
0.0003 |
| 416 |
LOSS OF LIBIDO |
3 |
0.0003 |
| 417 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
1 |
0.0003 |
| 418 |
OSTEOPENIA |
5 |
0.0003 |
| 419 |
PANIC ATTACK |
12 |
0.0003 |
| 420 |
RETINAL DETACHMENT |
3 |
0.0003 |
| 421 |
GENERALISED OEDEMA |
4 |
0.0003 |
| 422 |
TENDONITIS |
5 |
0.0003 |
| 423 |
ERYTHEMA MULTIFORME |
3 |
0.0003 |
| 424 |
DEFORMITY |
3 |
0.0003 |
| 425 |
PRE-EXISTING CONDITION IMPROVED |
2 |
0.0003 |
| 426 |
BLOOD BLISTER |
1 |
0.0003 |
| 427 |
NASAL DRYNESS |
2 |
0.0003 |
| 428 |
LACERATION |
3 |
0.0003 |
| 429 |
ARTERIOSCLEROSIS |
3 |
0.0003 |
| 430 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 431 |
BLEPHAROSPASM |
2 |
0.0003 |
| 432 |
PROCTALGIA |
2 |
0.0003 |
| 433 |
HYPERCHOLESTEROLAEMIA |
3 |
0.0003 |
| 434 |
ATELECTASIS |
3 |
0.0003 |
| 435 |
BREAST CANCER STAGE III |
2 |
0.0003 |
| 436 |
HERPES SIMPLEX |
2 |
0.0003 |
| 437 |
HAEMORRHOIDS |
6 |
0.0003 |
| 438 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 439 |
EXPOSURE DURING PREGNANCY |
19 |
0.0003 |
| 440 |
POLYP |
2 |
0.0003 |
| 441 |
GASTRITIS |
8 |
0.0003 |
| 442 |
IMMUNE SYSTEM DISORDER |
4 |
0.0003 |
| 443 |
STAPHYLOCOCCAL INFECTION |
10 |
0.0003 |
| 444 |
ABORTION SPONTANEOUS |
12 |
0.0003 |
| 445 |
LEFT VENTRICULAR DYSFUNCTION |
2 |
0.0003 |
| 446 |
EYELID PTOSIS |
3 |
0.0003 |
| 447 |
MOOD ALTERED |
8 |
0.0003 |
| 448 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
2 |
0.0003 |
| 449 |
ONYCHOCLASIS |
2 |
0.0003 |
| 450 |
LYMPHOEDEMA |
2 |
0.0003 |
| 451 |
LARGE INTESTINE POLYP |
2 |
0.0003 |
| 452 |
PRODUCT ODOUR ABNORMAL |
3 |
0.0003 |
| 453 |
WOUND |
8 |
0.0003 |
| 454 |
POOR QUALITY PRODUCT ADMINISTERED |
3 |
0.0003 |
| 455 |
INJURY |
20 |
0.0003 |
| 456 |
DERMATITIS ATOPIC |
15 |
0.0003 |
| 457 |
JOINT DISLOCATION |
3 |
0.0003 |
| 458 |
DRUG ERUPTION |
5 |
0.0003 |
| 459 |
THIRST |
5 |
0.0003 |
| 460 |
IMPAIRED QUALITY OF LIFE |
4 |
0.0003 |
| 461 |
APPARENT DEATH |
1 |
0.0003 |
| 462 |
INTERVERTEBRAL DISC PROTRUSION |
6 |
0.0003 |
| 463 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 464 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 465 |
BLINDNESS TRANSIENT |
2 |
0.0003 |
| 466 |
AMYLASE INCREASED |
1 |
0.0003 |
| 467 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0003 |
| 468 |
CEREBRAL DISORDER |
2 |
0.0003 |
| 469 |
NEOPLASM MALIGNANT |
18 |
0.0003 |
| 470 |
HYDRONEPHROSIS |
2 |
0.0003 |
| 471 |
DEPRESSED MOOD |
14 |
0.0003 |
| 472 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 473 |
EAR INFECTION |
7 |
0.0003 |
| 474 |
CHOLECYSTECTOMY |
3 |
0.0003 |
| 475 |
DEEP VEIN THROMBOSIS |
17 |
0.0003 |
| 476 |
INSURANCE ISSUE |
4 |
0.0003 |
| 477 |
LIPASE INCREASED |
2 |
0.0003 |
| 478 |
METASTASES TO LUNG |
3 |
0.0003 |
| 479 |
FOOD ALLERGY |
2 |
0.0003 |
| 480 |
LOW DENSITY LIPOPROTEIN INCREASED |
2 |
0.0003 |
| 481 |
THERAPY PARTIAL RESPONDER |
4 |
0.0003 |
| 482 |
SEXUAL DYSFUNCTION |
3 |
0.0003 |
| 483 |
DEPRESSION |
58 |
0.0003 |
| 484 |
BACTERAEMIA |
3 |
0.0003 |
| 485 |
NASAL DISCOMFORT |
2 |
0.0003 |
| 486 |
CHOLECYSTITIS |
3 |
0.0003 |
| 487 |
OBESITY |
4 |
0.0003 |
| 488 |
BLEPHARITIS |
1 |
0.0002 |
| 489 |
RHINITIS |
2 |
0.0002 |
| 490 |
MUSCLE DISORDER |
2 |
0.0002 |
| 491 |
SUBSTANCE ABUSE |
2 |
0.0002 |
| 492 |
POLYURIA |
2 |
0.0002 |
| 493 |
DYSPNOEA |
138 |
0.0002 |
| 494 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
7 |
0.0002 |
| 495 |
DEVICE MALFUNCTION |
17 |
0.0002 |
| 496 |
SPINAL COMPRESSION FRACTURE |
2 |
0.0002 |
| 497 |
AORTIC DISSECTION |
1 |
0.0002 |
| 498 |
APPLICATION SITE IRRITATION |
3 |
0.0002 |
| 499 |
POLLAKIURIA |
10 |
0.0002 |
| 500 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 501 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 502 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 503 |
ABSCESS LIMB |
1 |
0.0002 |
| 504 |
MYDRIASIS |
3 |
0.0002 |
| 505 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 506 |
PARANOIA |
4 |
0.0002 |
| 507 |
ANXIETY |
66 |
0.0002 |
| 508 |
PSYCHOLOGICAL TRAUMA |
2 |
0.0002 |
| 509 |
HIATUS HERNIA |
3 |
0.0002 |
| 510 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 511 |
NODULE |
3 |
0.0002 |
| 512 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 513 |
DEAFNESS |
6 |
0.0002 |
| 514 |
TREATMENT FAILURE |
19 |
0.0002 |
| 515 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 516 |
NAIL DISORDER |
2 |
0.0002 |
| 517 |
GRIP STRENGTH DECREASED |
2 |
0.0002 |
| 518 |
LYMPHOCYTE COUNT DECREASED |
4 |
0.0002 |
| 519 |
ASPARTATE AMINOTRANSFERASE INCREASED |
12 |
0.0002 |
| 520 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 521 |
JOINT RANGE OF MOTION DECREASED |
3 |
0.0002 |
| 522 |
ORAL PAIN |
5 |
0.0002 |
| 523 |
DRUG-INDUCED LIVER INJURY |
7 |
0.0002 |
| 524 |
THROAT IRRITATION |
10 |
0.0002 |
| 525 |
HEAVY MENSTRUAL BLEEDING |
2 |
0.0002 |
| 526 |
SINUS CONGESTION |
3 |
0.0002 |
| 527 |
DYSPHAGIA |
21 |
0.0002 |
| 528 |
EXOSTOSIS |
2 |
0.0002 |
| 529 |
NERVE COMPRESSION |
2 |
0.0002 |
| 530 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 531 |
THINKING ABNORMAL |
4 |
0.0002 |
| 532 |
PSORIASIS |
28 |
0.0002 |
| 533 |
CHOLELITHIASIS |
7 |
0.0002 |
| 534 |
EYE PAIN |
12 |
0.0002 |
| 535 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 536 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 537 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 538 |
CHRONIC KIDNEY DISEASE |
16 |
0.0002 |
| 539 |
BRONCHOSPASM |
3 |
0.0002 |
| 540 |
RED BLOOD CELL COUNT DECREASED |
6 |
0.0002 |
| 541 |
EYE INFLAMMATION |
2 |
0.0002 |
| 542 |
HYPERSOMNIA |
6 |
0.0002 |
| 543 |
SINUS BRADYCARDIA |
2 |
0.0002 |
| 544 |
APATHY |
3 |
0.0002 |
| 545 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
6 |
0.0002 |
| 546 |
HEPATOMEGALY |
2 |
0.0002 |
| 547 |
VITREOUS FLOATERS |
2 |
0.0002 |
| 548 |
DRUG EFFECT LESS THAN EXPECTED |
3 |
0.0002 |
| 549 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 550 |
HAEMATOCRIT DECREASED |
4 |
0.0002 |
| 551 |
BLOOD PRESSURE ABNORMAL |
4 |
0.0002 |
| 552 |
ANEURYSM |
1 |
0.0002 |
| 553 |
THERAPEUTIC RESPONSE UNEXPECTED |
9 |
0.0002 |
| 554 |
DRY EYE |
10 |
0.0002 |
| 555 |
BONE LOSS |
3 |
0.0002 |
| 556 |
BLOOD POTASSIUM DECREASED |
6 |
0.0002 |
| 557 |
POOR QUALITY DEVICE USED |
2 |
0.0002 |
| 558 |
EMOTIONAL DISTRESS |
24 |
0.0002 |
| 559 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 560 |
HAEMATEMESIS |
5 |
0.0002 |
| 561 |
PLEURAL EFFUSION |
12 |
0.0002 |
| 562 |
PSORIATIC ARTHROPATHY |
8 |
0.0002 |
| 563 |
DRUG LEVEL DECREASED |
2 |
0.0002 |
| 564 |
AMMONIA INCREASED |
1 |
0.0002 |
| 565 |
HIP ARTHROPLASTY |
3 |
0.0002 |
| 566 |
INITIAL INSOMNIA |
2 |
0.0002 |
| 567 |
EAR DISCOMFORT |
2 |
0.0002 |
| 568 |
OSTEOPOROSIS |
8 |
0.0002 |
| 569 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
5 |
0.0002 |
| 570 |
MUSCULOSKELETAL CHEST PAIN |
3 |
0.0002 |
| 571 |
TEMPERATURE INTOLERANCE |
2 |
0.0002 |
| 572 |
SKELETAL INJURY |
2 |
0.0002 |
| 573 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 574 |
BONE DENSITY DECREASED |
6 |
0.0002 |
| 575 |
UNINTENDED PREGNANCY |
2 |
0.0002 |
| 576 |
KNEE ARTHROPLASTY |
4 |
0.0002 |
| 577 |
RENAL PAIN |
2 |
0.0002 |
| 578 |
BREAST PAIN |
2 |
0.0002 |
| 579 |
JOINT INJURY |
4 |
0.0002 |
| 580 |
BODY HEIGHT DECREASED |
2 |
0.0002 |
| 581 |
ANAL FISSURE |
1 |
0.0002 |
| 582 |
NIGHT SWEATS |
6 |
0.0002 |
| 583 |
HALLUCINATION |
14 |
0.0002 |
| 584 |
ANAL ABSCESS |
1 |
0.0002 |
| 585 |
BACK INJURY |
2 |
0.0002 |
| 586 |
INTENTIONAL PRODUCT MISUSE |
16 |
0.0002 |
| 587 |
IMPAIRED HEALING |
6 |
0.0002 |
| 588 |
ASPIRATION |
2 |
0.0002 |
| 589 |
THERAPEUTIC RESPONSE DECREASED |
11 |
0.0002 |
| 590 |
GENERALISED TONIC-CLONIC SEIZURE |
3 |
0.0002 |
| 591 |
RESPIRATORY DISTRESS |
5 |
0.0002 |
| 592 |
EXPIRED PRODUCT ADMINISTERED |
6 |
0.0002 |
| 593 |
DIVERTICULITIS |
5 |
0.0002 |
| 594 |
NERVE INJURY |
2 |
0.0002 |
| 595 |
AGGRESSION |
9 |
0.0002 |
| 596 |
MATERNAL EXPOSURE DURING PREGNANCY |
16 |
0.0002 |
| 597 |
COLITIS ULCERATIVE |
8 |
0.0002 |
| 598 |
MALNUTRITION |
2 |
0.0002 |
| 599 |
INTESTINAL PERFORATION |
2 |
0.0002 |
| 600 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 601 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 602 |
ASTHMA |
20 |
0.0002 |
| 603 |
PRODUCT DOSE OMISSION IN ERROR |
5 |
0.0002 |
| 604 |
SUICIDAL IDEATION |
16 |
0.0002 |
| 605 |
INFLAMMATION |
9 |
0.0002 |
| 606 |
NEOPLASM |
2 |
0.0002 |
| 607 |
PALPITATIONS |
20 |
0.0002 |
| 608 |
SPINAL PAIN |
2 |
0.0002 |
| 609 |
SURGERY |
10 |
0.0002 |
| 610 |
WHEEZING |
10 |
0.0002 |
| 611 |
HYPERLIPIDAEMIA |
2 |
0.0002 |
| 612 |
DISTURBANCE IN ATTENTION |
9 |
0.0002 |
| 613 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 614 |
SYNOVITIS |
3 |
0.0002 |
| 615 |
THYROID CANCER |
2 |
0.0002 |
| 616 |
TOOTHACHE |
3 |
0.0002 |
| 617 |
PELVIC PAIN |
3 |
0.0002 |
| 618 |
BURSITIS |
2 |
0.0002 |
| 619 |
FIBROMYALGIA |
4 |
0.0002 |
| 620 |
TREATMENT NONCOMPLIANCE |
9 |
0.0002 |
| 621 |
ALANINE AMINOTRANSFERASE INCREASED |
10 |
0.0002 |
| 622 |
MUSCLE SPASTICITY |
2 |
0.0002 |
| 623 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 624 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 625 |
TENDON RUPTURE |
2 |
0.0002 |
| 626 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 627 |
HEPATIC STEATOSIS |
3 |
0.0002 |
| 628 |
ILEUS |
2 |
0.0002 |
| 629 |
MENTAL DISORDER |
7 |
0.0002 |
| 630 |
HAIR COLOUR CHANGES |
2 |
0.0002 |
| 631 |
TOOTH EXTRACTION |
2 |
0.0002 |
| 632 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 633 |
INTESTINAL OBSTRUCTION |
6 |
0.0002 |
| 634 |
FLATULENCE |
9 |
0.0002 |
| 635 |
CYSTITIS |
5 |
0.0002 |
| 636 |
PULMONARY FIBROSIS |
3 |
0.0002 |
| 637 |
POST PROCEDURAL COMPLICATION |
3 |
0.0002 |
| 638 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 639 |
INFUSION SITE PAIN |
2 |
0.0002 |
| 640 |
ERUCTATION |
3 |
0.0002 |
| 641 |
EAR PAIN |
3 |
0.0002 |
| 642 |
ANGINA UNSTABLE |
1 |
0.0002 |
| 643 |
HYPOAESTHESIA |
23 |
0.0002 |
| 644 |
NASAL CONGESTION |
9 |
0.0002 |
| 645 |
KIDNEY INFECTION |
3 |
0.0002 |
| 646 |
NEPHROLITHIASIS |
7 |
0.0002 |
| 647 |
JOINT STIFFNESS |
4 |
0.0002 |
| 648 |
DISABILITY |
3 |
0.0002 |
| 649 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
3 |
0.0002 |
| 650 |
SINUS DISORDER |
3 |
0.0002 |
| 651 |
THERAPEUTIC RESPONSE SHORTENED |
5 |
0.0002 |
| 652 |
VISUAL ACUITY REDUCED |
5 |
0.0002 |
| 653 |
BLOOD CHOLESTEROL INCREASED |
7 |
0.0002 |
| 654 |
MALIGNANT MELANOMA |
2 |
0.0001 |
| 655 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 656 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 657 |
DISCOMFORT |
9 |
0.0001 |
| 658 |
PULMONARY EMBOLISM |
14 |
0.0001 |
| 659 |
LIMB INJURY |
4 |
0.0001 |
| 660 |
SEIZURE |
17 |
0.0001 |
| 661 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
1 |
0.0001 |
| 662 |
BODY TEMPERATURE INCREASED |
3 |
0.0001 |
| 663 |
AKATHISIA |
2 |
0.0001 |
| 664 |
GINGIVAL BLEEDING |
2 |
0.0001 |
| 665 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 666 |
CHEST PAIN |
27 |
0.0001 |
| 667 |
CONTUSION |
14 |
0.0001 |
| 668 |
INFECTION |
21 |
0.0001 |
| 669 |
TOOTH LOSS |
3 |
0.0001 |
| 670 |
NEOPLASM PROGRESSION |
5 |
0.0001 |
| 671 |
ROAD TRAFFIC ACCIDENT |
6 |
0.0001 |
| 672 |
CARPAL TUNNEL SYNDROME |
2 |
0.0001 |
| 673 |
DYSPEPSIA |
14 |
0.0001 |
| 674 |
OSTEOARTHRITIS |
6 |
0.0001 |
| 675 |
LOSS OF CONSCIOUSNESS |
18 |
0.0001 |
| 676 |
OROPHARYNGEAL PAIN |
13 |
0.0001 |
| 677 |
IMPAIRED WORK ABILITY |
3 |
0.0001 |
| 678 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 679 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 680 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 681 |
VISION BLURRED |
19 |
0.0001 |
| 682 |
PRODUCT DISPENSING ERROR |
3 |
0.0001 |
| 683 |
COMPLICATION ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 684 |
DYSSTASIA |
4 |
0.0001 |
| 685 |
MUSCULOSKELETAL STIFFNESS |
12 |
0.0001 |
| 686 |
DYSPHONIA |
8 |
0.0001 |
| 687 |
ILLNESS |
14 |
0.0001 |
| 688 |
DYSURIA |
5 |
0.0001 |
| 689 |
CARDIOMYOPATHY |
2 |
0.0001 |
| 690 |
DEHYDRATION |
18 |
0.0001 |
| 691 |
STEVENS-JOHNSON SYNDROME |
3 |
0.0001 |
| 692 |
RESPIRATORY DISORDER |
4 |
0.0001 |
| 693 |
EPISTAXIS |
10 |
0.0001 |
| 694 |
SPEECH DISORDER |
7 |
0.0001 |
| 695 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 696 |
APHASIA |
4 |
0.0001 |
| 697 |
BLOOD COUNT ABNORMAL |
2 |
0.0001 |
| 698 |
COLITIS |
5 |
0.0001 |
| 699 |
TINNITUS |
6 |
0.0001 |
| 700 |
UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 701 |
THYROID DISORDER |
2 |
0.0001 |
| 702 |
MYALGIA |
22 |
0.0001 |
| 703 |
OEDEMA |
7 |
0.0001 |
| 704 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 705 |
COGNITIVE DISORDER |
6 |
0.0001 |
| 706 |
APNOEA |
1 |
0.0001 |
| 707 |
ACUTE MYELOID LEUKAEMIA |
2 |
0.0001 |
| 708 |
NERVOUS SYSTEM DISORDER |
4 |
0.0001 |
| 709 |
SLEEP DISORDER |
9 |
0.0001 |
| 710 |
ARTHRITIS |
10 |
0.0001 |
| 711 |
PAIN |
78 |
0.0001 |
| 712 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 713 |
CHEST DISCOMFORT |
13 |
0.0001 |
| 714 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
9 |
0.0001 |
| 715 |
HEAD INJURY |
4 |
0.0001 |
| 716 |
ABNORMAL BEHAVIOUR |
5 |
0.0001 |
| 717 |
HALLUCINATION, AUDITORY |
2 |
0.0001 |
| 718 |
MIGRAINE |
12 |
0.0001 |
| 719 |
INTENTIONAL PRODUCT USE ISSUE |
11 |
0.0001 |
| 720 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 721 |
HYPOTHYROIDISM |
4 |
0.0001 |
| 722 |
BLOOD DISORDER |
1 |
0.0001 |
| 723 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 724 |
ABDOMINAL DISTENSION |
13 |
0.0001 |
| 725 |
CONSTIPATION |
27 |
0.0001 |
| 726 |
MENTAL IMPAIRMENT |
3 |
0.0001 |
| 727 |
PRESYNCOPE |
3 |
0.0001 |
| 728 |
OEDEMA PERIPHERAL |
15 |
0.0001 |
| 729 |
ASPHYXIA |
1 |
0.0001 |
| 730 |
INJECTION SITE URTICARIA |
3 |
0.0001 |
| 731 |
LIVER INJURY |
3 |
0.0001 |
| 732 |
METASTASES TO BONE |
2 |
0.0001 |
| 733 |
BRONCHITIS |
9 |
0.0001 |
| 734 |
MANIA |
2 |
0.0001 |
| 735 |
HEART RATE INCREASED |
12 |
0.0001 |
| 736 |
VENTRICULAR TACHYCARDIA |
2 |
0.0001 |
| 737 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 738 |
BACK PAIN |
28 |
0.0001 |
| 739 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 740 |
RENAL FAILURE |
16 |
0.0001 |
| 741 |
ABDOMINAL PAIN |
28 |
0.0001 |
| 742 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 743 |
FUNGAL INFECTION |
4 |
0.0001 |
| 744 |
URINARY RETENTION |
4 |
0.0001 |
| 745 |
ABDOMINAL DISCOMFORT |
20 |
0.0001 |
| 746 |
PERICARDITIS |
2 |
0.0001 |
| 747 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 748 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 749 |
HAEMOGLOBIN DECREASED |
12 |
0.0001 |
| 750 |
PERIPHERAL SWELLING |
18 |
0.0001 |
| 751 |
IRRITABILITY |
7 |
0.0001 |
| 752 |
INSOMNIA |
31 |
0.0001 |
| 753 |
JOINT SWELLING |
14 |
0.0001 |
| 754 |
DIPLOPIA |
3 |
0.0001 |
| 755 |
AMENORRHOEA |
2 |
0.0001 |
| 756 |
METASTASES TO LIVER |
2 |
0.0001 |
| 757 |
COLD SWEAT |
2 |
0.0001 |
| 758 |
DRUG INTERACTION |
18 |
0.0001 |
| 759 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 760 |
GOUT |
2 |
0.0001 |
| 761 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 762 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 763 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 764 |
PALLOR |
3 |
0.0001 |
| 765 |
CRYING |
4 |
0.0001 |
| 766 |
MEMORY IMPAIRMENT |
15 |
0.0001 |
| 767 |
HYPERHIDROSIS |
14 |
0.0001 |
| 768 |
NECK PAIN |
6 |
0.0001 |
| 769 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 770 |
PHOTOPHOBIA |
2 |
0.0001 |
| 771 |
ABORTION INDUCED |
1 |
0.0001 |
| 772 |
UNEVALUABLE EVENT |
8 |
0.0001 |
| 773 |
MUSCULAR WEAKNESS |
12 |
0.0001 |
| 774 |
PROTEINURIA |
2 |
0.0001 |
| 775 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 776 |
ARTHRALGIA |
43 |
0.0001 |
| 777 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 778 |
INTERSTITIAL LUNG DISEASE |
5 |
0.0001 |
| 779 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 780 |
CHOKING |
2 |
0.0001 |
| 781 |
ORAL HERPES |
2 |
0.0001 |
| 782 |
ASCITES |
3 |
0.0001 |
| 783 |
PRODUCT DOSE OMISSION ISSUE |
30 |
0.0001 |
| 784 |
ABDOMINAL PAIN UPPER |
21 |
0.0001 |
| 785 |
ALOPECIA |
20 |
0.0001 |
| 786 |
PSYCHOTIC DISORDER |
3 |
0.0001 |
| 787 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 788 |
CATARACT |
6 |
0.0001 |
| 789 |
GASTROINTESTINAL DISORDER |
9 |
0.0001 |
| 790 |
INTENTIONAL SELF-INJURY |
2 |
0.0001 |
| 791 |
DRY MOUTH |
8 |
0.0001 |
| 792 |
NAUSEA |
78 |
0.0001 |
| 793 |
WEIGHT INCREASED |
22 |
0.0001 |
| 794 |
NEUTROPHIL COUNT DECREASED |
4 |
0.0001 |
| 795 |
MUSCLE SPASMS |
18 |
0.0001 |
| 796 |
THERAPY INTERRUPTED |
7 |
0.0001 |
| 797 |
THERAPY CESSATION |
5 |
0.0001 |
| 798 |
INJECTION SITE WARMTH |
2 |
0.0001 |
| 799 |
INFLUENZA LIKE ILLNESS |
8 |
0.0001 |
| 800 |
LIMB DISCOMFORT |
3 |
0.0001 |
| 801 |
PERITONITIS |
2 |
0.0001 |
| 802 |
FATIGUE |
75 |
0.0001 |
| 803 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 804 |
MUSCULOSKELETAL PAIN |
5 |
0.0001 |
| 805 |
PYREXIA |
33 |
0.0001 |
| 806 |
MOOD SWINGS |
3 |
0.0001 |
| 807 |
OFF LABEL USE |
82 |
0.0001 |
| 808 |
POOR QUALITY SLEEP |
2 |
0.0001 |
| 809 |
ACUTE KIDNEY INJURY |
14 |
0.0001 |
| 810 |
INFUSION RELATED REACTION |
6 |
0.0001 |
| 811 |
DECREASED APPETITE |
21 |
0.0001 |
| 812 |
VIRAL INFECTION |
3 |
0.0001 |
| 813 |
TACHYCARDIA |
8 |
0.0001 |
| 814 |
SYNCOPE |
9 |
0.0001 |
| 815 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 816 |
SEPSIS |
10 |
0.0001 |
| 817 |
SOMNOLENCE |
18 |
0.0001 |
| 818 |
SNEEZING |
2 |
0.0001 |
| 819 |
ANAEMIA |
17 |
0.0001 |
| 820 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 821 |
PANCREATITIS ACUTE |
2 |
0.0001 |
| 822 |
OXYGEN SATURATION DECREASED |
5 |
0.0001 |
| 823 |
HYPONATRAEMIA |
5 |
0.0001 |
| 824 |
ANGER |
3 |
0.0001 |
| 825 |
FLUSHING |
9 |
0.0001 |
| 826 |
DIARRHOEA |
57 |
0.0001 |
| 827 |
URINARY TRACT INFECTION |
15 |
0.0001 |
| 828 |
SINUSITIS |
9 |
0.0001 |
| 829 |
HAEMATURIA |
3 |
0.0001 |
| 830 |
GASTRIC DISORDER |
3 |
0.0001 |
| 831 |
ACCIDENTAL EXPOSURE TO PRODUCT |
9 |
0.0001 |
| 832 |
HYPOKALAEMIA |
4 |
0.0001 |
| 833 |
WEIGHT DECREASED |
24 |
0.0001 |
| 834 |
RENAL DISORDER |
4 |
0.0001 |
| 835 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
2 |
0.0001 |
| 836 |
COUGH |
24 |
0.0001 |
| 837 |
HEADACHE |
53 |
0.0001 |
| 838 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 839 |
MOBILITY DECREASED |
6 |
0.0001 |
| 840 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 841 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 842 |
STOMATITIS |
5 |
0.0001 |
| 843 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 844 |
NEURALGIA |
2 |
0.0001 |
| 845 |
DIZZINESS |
41 |
0.0001 |
| 846 |
RESTLESSNESS |
3 |
0.0001 |
| 847 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 848 |
AGITATION |
6 |
0.0001 |
| 849 |
ABASIA |
2 |
0.0001 |
| 850 |
INFLUENZA |
9 |
0.0001 |
| 851 |
VISUAL IMPAIRMENT |
10 |
0.0001 |
| 852 |
CONFUSIONAL STATE |
13 |
0.0001 |
| 853 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 854 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
16 |
0.0001 |
| 855 |
VOMITING |
37 |
0.0001 |
| 856 |
HEPATITIS |
2 |
0.0001 |
| 857 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 858 |
UNRESPONSIVE TO STIMULI |
2 |
0.0001 |
| 859 |
RHINORRHOEA |
5 |
0.0001 |
| 860 |
PNEUMONIA |
25 |
0.0001 |
| 861 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 862 |
AMNESIA |
5 |
0.0001 |
| 863 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 864 |
NERVOUSNESS |
4 |
0.0001 |
| 865 |
HAEMORRHAGE |
8 |
0.0001 |
| 866 |
SEDATION |
2 |
0.0001 |
| 867 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 868 |
BEDRIDDEN |
1 |
0.0001 |
| 869 |
DISORIENTATION |
3 |
0.0001 |
| 870 |
PANCREATITIS |
4 |
0.0001 |
| 871 |
HYPERTENSION |
16 |
0.0001 |
| 872 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 873 |
INJECTION SITE BRUISING |
6 |
0.0001 |
| 874 |
INJECTION SITE PRURITUS |
5 |
0.0001 |
| 875 |
DRUG EFFECT DECREASED |
4 |
0.0001 |
| 876 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 877 |
DRUG INTOLERANCE |
7 |
0.0001 |
| 878 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 879 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 880 |
HAEMOPTYSIS |
2 |
0.0001 |
| 881 |
APHONIA |
1 |
0.0001 |
| 882 |
DEMENTIA |
2 |
0.0001 |
| 883 |
PAIN IN EXTREMITY |
21 |
0.0001 |
| 884 |
PAIN IN JAW |
2 |
0.0001 |
| 885 |
CONVULSION |
4 |
0.0001 |
| 886 |
PRODUCT SUBSTITUTION ISSUE |
4 |
0.0001 |
| 887 |
ANOSMIA |
1 |
0.0001 |
| 888 |
SEPTIC SHOCK |
3 |
0.0001 |
| 889 |
BONE PAIN |
4 |
0.0001 |
| 890 |
LIVER DISORDER |
3 |
0.0001 |
| 891 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 892 |
PREMATURE BABY |
2 |
0.0001 |
| 893 |
HEPATIC FAILURE |
2 |
0.0001 |
| 894 |
NEUTROPENIA |
9 |
0.0001 |
| 895 |
MALAISE |
29 |
0.0001 |
| 896 |
SUICIDE ATTEMPT |
4 |
0.0001 |
| 897 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 898 |
ADVERSE EVENT |
6 |
0.0001 |
| 899 |
GYNAECOMASTIA |
2 |
0.0001 |
| 900 |
ANKLE FRACTURE |
1 |
0.0001 |
| 901 |
CARDIAC DISORDER |
6 |
0.0001 |
| 902 |
ASTHENIA |
24 |
0.0001 |
| 903 |
ARRHYTHMIA |
3 |
0.0001 |
| 904 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 905 |
MULTIPLE SCLEROSIS |
3 |
0.0001 |
| 906 |
INJECTION SITE HAEMORRHAGE |
5 |
0.0001 |
| 907 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 908 |
MOVEMENT DISORDER |
2 |
0.0001 |
| 909 |
HYPOGLYCAEMIA |
3 |
0.0001 |
| 910 |
LUNG DISORDER |
3 |
0.0001 |
| 911 |
EYE DISORDER |
2 |
0.0001 |
| 912 |
TREMOR |
10 |
0.0001 |
| 913 |
LEUKOPENIA |
3 |
0.0001 |
| 914 |
GAIT INABILITY |
2 |
0.0001 |
| 915 |
CELLULITIS |
3 |
0.0001 |
| 916 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 917 |
FLUID RETENTION |
3 |
0.0001 |
| 918 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 919 |
INJECTION SITE PAIN |
18 |
0.0001 |
| 920 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 921 |
HOSPITALISATION |
9 |
0.0001 |
| 922 |
DELIRIUM |
2 |
0.0001 |
| 923 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
3 |
0.0001 |
| 924 |
FALL |
19 |
0.0001 |
| 925 |
HEART RATE DECREASED |
2 |
0.0001 |
| 926 |
HYPOXIA |
2 |
0.0001 |
| 927 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 928 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 929 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
2 |
0.0001 |
| 930 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 931 |
HYPOTENSION |
11 |
0.0001 |
| 932 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 933 |
NASOPHARYNGITIS |
10 |
0.0001 |
| 934 |
ARTHROPATHY |
3 |
0.0001 |
| 935 |
DYSARTHRIA |
2 |
0.0001 |
| 936 |
HOT FLUSH |
4 |
0.0001 |
| 937 |
NEUROPATHY PERIPHERAL |
5 |
0.0001 |
| 938 |
GAIT DISTURBANCE |
10 |
0.0001 |
| 939 |
HERPES ZOSTER |
3 |
0.0001 |
| 940 |
INJECTION SITE SWELLING |
4 |
0.0001 |
| 941 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 942 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 943 |
COVID-19 |
9 |
0.0001 |
| 944 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 945 |
DRUG DOSE OMISSION BY DEVICE |
4 |
0.0001 |
| 946 |
DISEASE PROGRESSION |
6 |
0.0001 |
| 947 |
DEVICE BREAKAGE |
2 |
0.0000 |
| 948 |
COMPLETED SUICIDE |
4 |
0.0000 |
| 949 |
PLATELET COUNT DECREASED |
5 |
0.0000 |
| 950 |
HYPOACUSIS |
2 |
0.0000 |
| 951 |
BALANCE DISORDER |
4 |
0.0000 |
| 952 |
DEVICE LEAKAGE |
2 |
0.0000 |
| 953 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 954 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 955 |
FEELING ABNORMAL |
11 |
0.0000 |
| 956 |
ADVERSE DRUG REACTION |
4 |
0.0000 |
| 957 |
RHEUMATOID ARTHRITIS |
5 |
0.0000 |
| 958 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 959 |
INJECTION SITE REACTION |
3 |
0.0000 |
| 960 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 961 |
COMA |
2 |
0.0000 |
| 962 |
DYSGEUSIA |
3 |
0.0000 |
| 963 |
AGEUSIA |
1 |
0.0000 |
| 964 |
DIABETES MELLITUS |
3 |
0.0000 |
| 965 |
FOETAL EXPOSURE DURING PREGNANCY |
3 |
0.0000 |
| 966 |
CARDIAC ARREST |
3 |
0.0000 |
| 967 |
MEDICATION ERROR |
2 |
0.0000 |
| 968 |
ANGINA PECTORIS |
1 |
0.0000 |
| 969 |
LETHARGY |
2 |
0.0000 |
| 970 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 971 |
DRUG WITHDRAWAL SYNDROME |
3 |
0.0000 |
| 972 |
CHILLS |
4 |
0.0000 |
| 973 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 974 |
VERTIGO |
2 |
0.0000 |
| 975 |
DRUG DOSE OMISSION |
5 |
0.0000 |
| 976 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 977 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 978 |
CARDIAC FAILURE |
2 |
0.0000 |
| 979 |
BLINDNESS |
1 |
0.0000 |
| 980 |
INJECTION SITE ERYTHEMA |
3 |
0.0000 |
| 981 |
MYOCARDIAL INFARCTION |
4 |
0.0000 |
| 982 |
DEVICE ISSUE |
2 |
0.0000 |
| 983 |
BREAST CANCER |
2 |
0.0000 |
| 984 |
BLOOD GLUCOSE INCREASED |
4 |
0.0000 |
| 985 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 986 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 987 |
INCORRECT DOSE ADMINISTERED |
4 |
0.0000 |
| 988 |
DEATH |
12 |
0.0000 |
| 989 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |